The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification
ConclusionsVisual-registration and image-fusion targeting strategies combined had the highest detection rate for clinically significant cancers. Targeted prostate biopsy should be performed using both strategies together.Patient summaryWe compared two prostate cancer biopsy strategies: visual registration and image fusion. A combination of the two strategies found the most clinically important cancers and should be used together whenever targeted biopsy is being performed.
Source: European Urology - Category: Urology & Nephrology Source Type: research
More News: Academia | Cancer | Cancer & Oncology | Clinical Trials | Computers | MRI Scan | Prostate Cancer | Statistics | Study | Ultrasound | Urinary Tract Infections | Urology & Nephrology